Total Payments
$6,686
2022 Payments
$100.00
Companies
5
Transactions
14
Medicare Patients
757
Medicare Billing
$135,220
Payment Breakdown by Category
Consulting$4,850 (72.5%)
Travel$743.07 (11.1%)
Other$700.00 (10.5%)
Food & Beverage$378.68 (5.7%)
Education$14.14 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,850 | 3 | 72.5% |
| Travel and Lodging | $743.07 | 2 | 11.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $700.00 | 1 | 10.5% |
| Food and Beverage | $378.68 | 7 | 5.7% |
| Education | $14.14 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $5,511 | 5 | $0 (2020) |
| PFIZER INC. | $700.00 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $334.55 | 5 | $0 (2022) |
| AbbVie, Inc. | $126.28 | 2 | $0 (2017) |
| VERTEX PHARMACEUTICALS INCORPORATED | $14.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $100.00 | 1 | Gilead Sciences, Inc. ($100.00) |
| 2020 | $5,511 | 5 | AstraZeneca Pharmaceuticals LP ($5,511) |
| 2019 | $98.87 | 1 | Gilead Sciences, Inc. ($98.87) |
| 2017 | $976.10 | 7 | PFIZER INC. ($700.00) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2022 | Gilead Sciences, Inc. | Cayston (Drug) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: RESP | ||||||
| 05/26/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $453.60 | General |
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $289.47 | General |
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $17.85 | General |
| 11/01/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $98.87 | General |
| 10/04/2017 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug) | Education | In-kind items and services | $14.14 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 08/21/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $2.50 | General |
| 05/17/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 05/11/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: Endocrinology | ||||||
| 04/25/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $120.78 | General |
| Category: Endocrinology | ||||||
| 04/10/2017 | PFIZER INC. | VFEND (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $700.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/21/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $8.18 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 241 | 451 | $127,737 | $44,402 |
| 2022 | 6 | 200 | 394 | $81,528 | $37,210 |
| 2021 | 6 | 168 | 342 | $66,058 | $32,308 |
| 2020 | 4 | 148 | 252 | $51,633 | $21,300 |
Total Patients
757
Total Services
1,439
Medicare Billing
$135,220
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 165 | $48,657 | $16,104 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 133 | $35,779 | $14,948 | 41.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 27 | $15,300 | $3,887 | 25.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 58 | $11,997 | $3,767 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 32 | $5,519 | $2,407 | 43.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $5,338 | $1,732 | 32.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $1,860 | $806.40 | 43.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 12 | 12 | $3,287 | $750.72 | 22.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 162 | $30,132 | $13,837 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 48 | 113 | $25,535 | $12,148 | 47.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $13,000 | $6,604 | 50.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 49 | $6,909 | $2,801 | 40.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 18 | 19 | $2,945 | $1,106 | 37.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 11 | 11 | $3,007 | $713.51 | 23.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 63 | 130 | $28,985 | $15,163 | 52.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 38 | 118 | $21,538 | $10,297 | 47.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 18 | $5,850 | $3,047 | 52.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 30 | $4,120 | $1,822 | 44.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 17 | $2,635 | $1,040 | 39.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 29 | $2,930 | $939.31 | 32.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 54 | 95 | $21,145 | $8,535 | 40.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 39 | $13,275 | $4,570 | 34.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 16 | 43 | $7,733 | $3,880 | 50.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 33 | 51 | $7,140 | $3,496 | 49.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 12 | 24 | $2,340 | $819.12 | 35.0% |
About Dr. Denis Hadjiliadis, MD
Dr. Denis Hadjiliadis, MD is a Pulmonary Disease healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801829684.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denis Hadjiliadis, MD has received a total of $6,686 in payments from pharmaceutical and medical device companies, with $100.00 received in 2022. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($4,850).
As a Medicare-enrolled provider, Hadjiliadis has provided services to 757 Medicare beneficiaries, totaling 1,439 services with total Medicare billing of $135,220. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Philadelphia, PA
- Active Since 07/07/2006
- Last Updated 09/13/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1801829684
Products in Payments
- VFEND (Drug) $700.00
- Creon (Drug) $126.28
- Cayston (Drug) $100.00
- ORKAMBI (Drug) $14.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Philadelphia
Gerard Criner, Md, MD
Pulmonary Disease — Payments: $945,674
Pulmonary Disease $945,674
Jeffrey Edelson, M.d, M.D
Pulmonary Disease — Payments: $437,125
Pulmonary Disease $437,125
Steven Geller, Do, DO
Pulmonary Disease — Payments: $251,222
Pulmonary Disease $251,222
Parth Rali, Md, MD
Pulmonary Disease — Payments: $232,570
Pulmonary Disease $232,570
Boyd Hehn, Md, MD
Pulmonary Disease — Payments: $139,719
Pulmonary Disease $139,719
Edward Schulman, Md, MD
Pulmonary Disease — Payments: $132,370
Pulmonary Disease $132,370